tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Pro Medicus upgraded to Buy from Neutral at Goldman Sachs

Goldman Sachs upgraded Pro Medicus to Buy from Neutral with a price target of A$76, up from A$57.90. The firm expects the adoption of Pro Medicus’ technology to expand and its new estimates imply a 22% EBITDA compound annual growth rate from FY23-26.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

See today’s best-performing stocks on TipRanks >>

Read More on PMCUF:

Disclaimer & DisclosureReport an Issue

1